HCM is a global alternative investment management firm launched in 1992. Since its inception, the company has developed a diversified investment platform that includes hedge funds, traditional investment management products and debt and private equity investments with longer-term holding periods. With over 300 employees, including almost 100 investment professionals, HCM manages approximately $21 billion of capital for some of the world’s most prominent institutional investors, public and corporate pension funds, endowments, foundations and family offices.
| Company | Date | Round | Size | Participants |
| EUSA Pharma | 11/06 | Venture Round | $18.6M | 16 |
| EUSA Pharma | 12/05 | Venture Round | $12.5M | 5 |
| BravoSolution | 8/05 | Venture Round | $6.5M | 13 |
| Pharmacopeia | 7/05 | Venture Round | $7.63M | 10 |
| ACE*COMM | 3/05 | Venture Round | $2.3M | 8 |
| Lexar Media | 3/05 | Venture Round | $60M | 2 |
